Provider

The Drug Enforcement Administration says the digital pharmacy wrongfully distributed thousands of prescription stimulants for ADHD, including Adderall.

Telemedicine use has declined since the height of the COVID-19 pandemic. Providers can rethink how they use telehealth to get the most out of the modality and improve care.

Click Therapeutics received FDA Breakthrough Device Designation for a prescription digital therapeutic for episodic migraine, and Superior HealthPlan announced a home care partnership with MedArrive and Brave Health.

QmTRIAGE analyzes 2D full-field digital mammography to flag abnormalities for radiologists' review.

Sanjula Jain, senior vice president of market strategy and chief research officer at Trilliant Health, discusses the future of virtual care and how emerging retail players will affect the industry.

The study follows the pioneering discovery in 2015 when ultrasound was used to clear protein markers for Alzheimer's.

Also, a Thai language speech recognition AI has been deployed for screening depression in Thailand.

It is offering free two-week access to the FibriCheck feature on its app for the first 100,000 users.   

Under the multiyear strategic partnership Anumana will conduct a clinical-validation trial and seek FDA De Novo classification for the algorithm.

Disease detection company Cardiosense, sustainable pill bottle maker Cabinet Health, testing company LumiraDx and physician engagement platform KeyOps also garner investments.